Akt2 relaxes podocytes in chronic kidney disease

A signaling cascade is activated in podocytes to induce survival and cope with stress during advanced glomerular disease, a new study shows. The findings may also explain why the immunosuppressor sirolimus, an inhibitor of this pathway, can cause proteinuria in a subset of patients with chronic kidney disease (pages 1288–1296).

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Podocyte function under conditions of nephron reduction.

Marina Corral Spence

References

  1. 1

    Reiser, J. & Sever, S. Annu. Rev. Med. 64, 357–366 (2013).

  2. 2

    Canaud, G. et al. Nat. Med. 19, 1288–1296 (2013).

  3. 3

    Wei, C. et al. Nat. Med. 14, 55–63 (2008).

  4. 4

    Nagase, M. & Fujita, T. Nat. Rev. Nephrol. 9, 86–98 (2013).

  5. 5

    Sarbassov, D.D. et al. Mol. Cell 22, 159–168 (2006).

  6. 6

    Laplante, M. & Sabatini, D.M. Cell 149, 274–293 (2012).

  7. 7

    Huber, T.B. et al. Mol. Cell Biol. 23, 4917–4928 (2003).

  8. 8

    Nozaki, S. et al. Cell Signal. 25, 1361–1371 (2013).

  9. 9

    Diekmann, F. et al. Transplant. Rev. (Orlando) 26, 27–29 (2012).

  10. 10

    Gödel, M. et al. J. Clin. Invest. 121, 2197–2209 (2011).

  11. 11

    Kistler, A.D. et al. Kidney Int. 81, 1053–1055 (2012).

  12. 12

    Yaddanapudi, S. et al. J. Clin. Invest. 121, 3965–3980 (2011).

Download references

Author information

Correspondence to Jochen Reiser.

Ethics declarations

Competing interests

J.R. is an inventor on issued and pending patents on new mechanisms and technologies for proteinuric kidney diseases. He stands to gain royalties from the commercialization of these technologies.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Reiser, J. Akt2 relaxes podocytes in chronic kidney disease. Nat Med 19, 1212–1213 (2013). https://doi.org/10.1038/nm.3357

Download citation

Further reading